Standout Papers

Antiangiogenic scheduling of chemotherapy improves efficacy against experimental drug-resistan... 2000 2026 2008 2017 1.3k
  1. Antiangiogenic scheduling of chemotherapy improves efficacy against experimental drug-resistant cancer. (2000)
    Catherine Butterfield, Birgit M. Kräling et al. PubMed

Immediate Impact

1 by Nobel laureates 34 from Science/Nature 83 standout
Sub-graph 1 of 20

Citing Papers

Targeting the tumour vasculature: from vessel destruction to promotion
2024 Standout
A view on drug resistance in cancer
2019 StandoutNature
1 intermediate paper

Works of Blair Marshall being referenced

Antiangiogenic scheduling of chemotherapy improves efficacy against experimental drug-resistant cancer.
2000 Standout

Author Peers

Author Last Decade Papers Cites
Blair Marshall 786 624 216 504 10 1.7k
Birgit M. Kräling 979 731 285 256 12 1.8k
K. Peter Hirth 1330 513 366 672 14 2.2k
Bin Shi 1140 839 110 268 15 2.0k
Vesselina G. Cooke 1036 423 209 604 12 2.1k
Beryl Y. Eve 676 796 230 338 14 1.5k
Karol Watson 969 519 109 232 14 1.7k
Raymond M. Shaheen 1334 751 117 360 19 2.0k
Nader Hanna 722 589 254 206 16 1.6k
Fabienne Baffert 958 428 99 224 19 1.5k
Kamila Naxerova 776 739 115 249 25 1.7k

All Works

Loading papers...

Rankless by CCL
2026